Infection is an Independent Predictor of Death in Diffuse Large B Cell Lymphoma

To identify risk factors for infection in patients with diffuse large B cell lymphoma (DLBCL) undergoing rituximab, cyclophosphamide, vincristine, adriamycin and prednisolone (R-CHOP) treatment. All patients with DLBCL who received R-CHOP from 2004–2014 in a tertiary Australian hospital were identif...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Sci Rep
Hlavní autoři: Dendle, Claire, Gilbertson, Michael, Spelman, Tim, Stuart, Rhonda L., Korman, Tony M., Thursky, Karin, Opat, Stephen, McQuilten, Zoe
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2017
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5493675/
https://ncbi.nlm.nih.gov/pubmed/28667319
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-017-04495-x
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky